GentiBio raises $157m through Series A funding round

GentiBio raises $157m through Series A funding round

Source: 
Pharmaceutical Business Review
snippet: 

Biotherapeutics company GentiBio has raised $157m through a Series A funding round, which was led by Matrix Capital Management.